Increasingly, surgery is being used to
combat obesity.
The most common weight loss surgery in
Europe and Australia is the
adjustable gastric band where a
silicone ring is placed around the top
of the stomach to help restrict the
amount of food eaten in a sitting. This
surgery has been FDA approved in the
United States since 2001 but has been
being used in other parts of the world
since the early 1990s. It is considered
the safest and least invasive of the
available weight loss surgeries such as
Roux-en-Y gastric bypass surgery (RNY),
biliopancreatic diversion, and stomach
stapling (also known as "vertical
banded gastroplasty", VBG).
Unlike those more invasive techniques
the band surgery does not cut into or
reroute any of the digestive tract and
is completely reversible. Removing the
implant returns the stomach to its
pre-surgical norm. All of these
surgeries can be done laparoscopically.
The more invasive of the surgeries
usually bypass or remove some portion
of the patient's intestines which
causes malabsorption and dumping.
All of these surgeries come with
risk to the patient.
For instance a recent study by the U.S.
Department of Health and Human Service
showed a 40% complication rate within
180 days of bariatric
surgery. Moreover these
surgeries do not guarantee either
successful weight loss or reduced
morbidity and mortality. Patients are
also required to make lifelong changes
to their diet if they are to keep the
lost weight off in the long term.
Therefore, as with any major surgery,
patients need to carefully evalute the
long term ramifications of their
choice.
